Advertisement
News
Subscribe to MDT Magazine News

Neuro Kinetics to Showcase I-Portal® Research at Brain Injury Awareness Day on Capitol Hill

March 15, 2011 8:33 am | by Bio-Medicine.Org | Comments

PITTSBURGH, March 15, 2011 /- Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical diagnostic equipment used worldwide for neurophysiologic/neurotologic testing, said today that it will showcase its eye-tracking I-Portal® technology and the...

TOPICS:

Healthier Healing for Hip Resurfacing - ICAP Ocean Tomo Announces Auction of an Advanced Hip Cap for Electromagnetic Tissue Stimulation by Neue Magnetodyn.

March 15, 2011 8:33 am | by Bio-Medicine.Org | Comments

CHICAGO, March 15, 2011 /- Developed by Neue Magnetodyn and represented by ICAP Ocean Tomo , this technology discloses an advanced hip cap for electromagnetic tissue stimulation. The assets in this portfolio will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March...

TOPICS:

Applied Science Laboratories Releases Revolutionary Eye Tracking Analysis Software

March 15, 2011 8:33 am | by Bio-Medicine.Org | Comments

BEDFORD, Mass., March 15, 2011 /- Applied Science Laboratories, the true authority on eye tracking, has released its highly anticipated analysis software, ASL Results for the Mobile Eye solution. This revolutionary program makes measuring consumer response, human behavior and physiology...

TOPICS:
Advertisement

Southern Home Medical Equipment Engages Northern Virginia Based Waterford Holdings Group to Evaluate and Consider Acquisition Candidates in the Mid-Atlantic Area

March 15, 2011 8:33 am | by Bio-Medicine.Org | Comments

LYMAN, S.C., March 15, 2011 /- Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, has targeted the Mid-Atlantic region for expansion and growth.  After two...

TOPICS:

Electricity Sparks Interest in New Technologies and Cosmeceuticals for Aging Skin

March 15, 2011 8:32 am | by Bio-Medicine.Org | Comments

SCHAUMBURG, Ill., MARCH 15, 2011/PRNewswire-USNewswire/ -- It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of...

TOPICS:

UMass stem cell bank teams with UK version

March 15, 2011 7:40 am | by Mass High Tech: The Journal of New England Technology | Comments

The University of Massachusetts Human Stem Cell Bank and Registry and the United Kingdom Stem Cell Bank plan to collaborate on various areas around stem cell categorization, distribution and possible funding for joint research projects, under an agreement signed today in Hertfordshire, England.

Biodel moves diabetes drug targets to trial

March 15, 2011 7:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Biodel Inc., a diabetes-focused therapeutics firm in Danbury, Conn., is ushering two new insulin drug candidates into Phase 1 clinical studies, the company announced today.

TV Personality Vanessa Minnillo Teams Up With Bayer and March of Dimes to Launch National Folate Awareness Campaign

March 15, 2011 7:37 am | by Bio-Medicine.Org | Comments

WHITE PLAINS, N.Y. and WAYNE, N.J., March 15, 2011 /- Vanessa Minnillo is making it a priority to share an important public health message with women nationwide. Minnillo is working with March of Dimes® and Bayer HealthCare Pharmaceuticals to help educate all women of reproductive...

TOPICS:
Advertisement

Survey Sampling International Names Chris DeAngelis to Head New SSI Health

March 15, 2011 7:37 am | by Bio-Medicine.Org | Comments

SHELTON, Conn., March 15, 2011 /- Survey Sampling International (SSI)—the leading global provider of online and offline sampling solutions—has appointed Chris DeAngelis to head its new SSI Health business, created to support the unique sampling requirements of health-related...

TOPICS:

FDA Approves Gadavist for Central Nervous System Scans

March 15, 2011 7:33 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 15, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system. (Logo:...

TOPICS:

Leisureworld Announces March Dividend

March 15, 2011 6:45 am | by The Associated Press | Comments

Leisureworld Senior Care Corporation (TSX: LW) today announced that the Company's dividend for March, 2011 will be $0.0708 per share, representing $0.85 per share on an annualized basis. Payment will be made on April 15, 2011 to shareholders of record March 31, 2011.Leisureworld's dividends...

Ford Blue Oval Scholarships Available for San Antonio High School Students

March 15, 2011 6:38 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., SAN ANTONIO, Texas, March 14, 2011 — In partnership with Ford Motor Company Fund and Community Services, the SME Education Foundation announces the 2011 Ford Blue Oval Scholarship program for graduating high school seniors in Bexar County, Texas. As part of their...

OEMs, Suppliers Exploring Cutting-Edge Technologies for Composite Materials at AeroDef Manufacturing in April

March 15, 2011 5:33 am | by Society of Manufacturing Engineers | Comments

ANAHEIM, March 14, 2011 — The aerospace industry's unrelenting need to enhance the performance of commercial and military aircraft is constantly driving the development of improved high-performance structural materials. More

NewCardio to Conduct Corporate Update Conference Call on March 29, 2011

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., March 15, 2011 /- NewCardio, Inc. (OTC Bulletin Board: NWCI ), a cardiovascular diagnostic solutions developer, announced today that the Company expects to file its Form 10-K for the year ended December 31, 2010 on March 29, 2011 and management will conduct a...

TOPICS:

Matakina and PenRad Sign Letter of Intent to Display Volparaâ„¢ Volumetric Breast Density Results on Mammography Review Station

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

LAS VEGAS, March 15, 2011 /- Matakina International, Limited of New Zealand and PenRad Technologies, Inc., a leader in medical image and information management, today announced that the companies have signed a Letter of Intent (LOI) to use the PenRad Mammography Information System (MIS)...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading